A rationally designed nanoparticle for RNA interference therapy in B-lineage lymphoid malignancies

The purposes of the present study were to further evaluate the biologic significance of the CD22ΔE12 molecular lesion and determine if it could serve as a molecular target for RNA interference (RNAi) therapy. We show that both pediatric and adult B-lineage lymphoid malignancies are characterized by...

Descripción completa

Detalles Bibliográficos
Autores principales: Uckun, Fatih M., Qazi, Sanjive, Ma, Hong, Yin, Lichen, Cheng, Jianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292938/
https://www.ncbi.nlm.nih.gov/pubmed/25599086
http://dx.doi.org/10.1016/j.ebiom.2014.10.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292938/
https://www.ncbi.nlm.nih.gov/pubmed/25599086
http://dx.doi.org/10.1016/j.ebiom.2014.10.013

Ejemplares similares